@FierceBiotech: Pfizer inks licensing deal with Russia's SatRx for diabetes drug. Release | Follow @FierceBiotech
@JohnCFierce: So K-V says that if the FDA doesn't ride to its rescue on Makena comp, it's going bankrupt in a few months. Buh-bye. More | Follow @JohnCFierce
@RyanMFierce: Interesting biotech startup opportunity: nanoparticles that reduce amount of active drug needed combat clots. More | Follow @RyanMFierce
> After going private in 2007, device and drug company Bausch & Lomb might decide to hop back aboard the public markets, unnamed sources told The Wall Street Journal. Article
> After losing a legal battle to cut ties with marketing partner Takeda Pharmaceutical, Sucampo Pharmacueticals ($SCMP) is reaching out to the company. More
> Alexza Pharmaceuticals ($ALXA) said that the FDA has accepted drug developer's latest NDA for the antipsychotic drug Adasuve and gave the company a PDUFA data of Dec. 21, 2012. Item
> Xconomy takes a look at Novo Nordisk's plans for an R&D facility in Seattle. Article
Pharma News
@FiercePharma: Top EMA lawyer jumps ship for SIdley Austin, private firm repping pharma companies. Agency investigates--FT. More | Follow @FiercePharma
> Pfizer trimming health claims on Centrum. Story
> NICE turns down Avastin for breast cancer. News
> K-V says it will go bankrupt without FDA intervention. Article
Medical Device News
@FierceMedDev: While purchasers praise the FDA's device ID plan, members of the industry remain wary. Item | Follow @FierceMedDev
@MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce
@DamianFierce: Roche gets its second FDA diagnostic approval this week, this time for a virus test. Story | Follow @DamianFierce
> Purchasers praise device ID plan, AdvaMed remains wary. News
> r4 Vascular nabs 510(k) for quick-inflate balloon catheter. More
> Roche gets FDA approval for cytomegalovirus diagnostic. Article
> FDA device unit looking out for 'Twilight' fans' eyes. More
And Finally… Harvard scientists have designed drug-coated nanoparticles that can combat clots and could serve as vehicles for other treatments. Report